ClinConnect ClinConnect Logo
Search / Trial NCT05776550

Safety and Efficacy of Distal Radial Approach (SAFE-BOX)

Launched by YONSEI UNIVERSITY · Mar 8, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The SAFE-BOX trial is a study looking at a new way to perform heart procedures called the distal radial approach. This method involves accessing the heart through the wrist, which may be safer and more comfortable for patients. The trial is currently recruiting participants who are at least 20 years old and need a coronary angiography or other heart interventions. To participate, patients must have a noticeable radial artery in their wrist that the doctors can easily feel.

If you decide to join the trial, you will be part of a group that helps researchers understand how safe and effective this new method is. The study is open to all genders, and it is important to note that some people may not be eligible, such as those with a very small or hard-to-find radial artery, pregnant women, or anyone the researcher feels is not suitable for the study. Your participation could contribute to finding better ways to treat heart conditions!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients over 20 years of age
  • 2. Patients requiring coronary angiography or intervention
  • 3. Patients with palpable distant radial artery
  • Exclusion Criteria:
  • 1. Patients with distant radial artery too small or not palpable
  • 2. Pregnant women
  • 3. Patients not appropriate for the researcher to judge

About Yonsei University

Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.

Locations

Yongin, Gyeonggi Do, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Yongcheol Kim, MD, PhD

Study Director

Severance Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials